FDA Import Refusal 799-4053787-1/11/1 — Novartis Pharmaceuticals Canada Inc.

Novartis Pharmaceuticals Canada Inc. — FEI 3002260858

The FDA refused shipment 799-4053787-1/11/1 from Novartis Pharmaceuticals Canada Inc. (Canada) on Apr 18, 2023. The refused product falls under Drugs and Biologics — ANTI-DIABETIC N.E.C.. Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal details

Date
Apr 18, 2023
Country
Canada
Product Category
Drugs and Biologics
Product Code
61PCL99 ANTI-DIABETIC N.E.C.
Charges
75

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.